US Edition
Published • loading... • Updated
Defining safety parameters for first-trimester malaria treatment trials: stakeholder views from Real-Time Delphi survey
Summary by researchsquare.com
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Defining safety parameters for first-trimester malaria treatment trials: stakeholder views from Real-Time Delphi survey
Background In 2022, the World Health Organisation recommended artemether-lumefantrine as the first-line treatment for uncomplicated malaria in first-trimester pregnancy. However, emerging drug resistance and WHO’s recommendation for treatment diversification necessitate research...
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
